A genetic interaction is inferred when mutations in separate genes, each of which alone causes a minimal phenotype, result in a significant growth defect under a given condition when combined in the same cell.

Publication

A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities.

Vizeacoumar FJ, Arnold R, Vizeacoumar FS, Chandrashekhar M, Buzina A, Young JT, Kwan JH, Sayad A, Mero P, Lawo S, Tanaka H, Brown KR, Baryshnikova A, Mak AB, Fedyshyn Y, Wang Y, Brito GC, Kasimer D, Makhnevych T, Ketela T, Datti A, Babu M, Emili A, Pelletier L, Wrana J, Wainberg Z, Kim PM, Rottapel R, O'Brien CA, Andrews B, Boone C, Moffat J

Improved efforts are necessary to define the functional product of cancer mutations currently being revealed through large-scale sequencing efforts. Using genome-scale pooled shRNA screening technology, we mapped negative genetic interactions across a set of isogenic cancer cell lines and confirmed hundreds of these interactions in orthogonal co-culture competition assays to generate a high-confidence genetic interaction network of differentially essential or ... [more]

Mol. Syst. Biol. Oct. 10, 2013; 9(0);696 [Pubmed: 24104479]

Throughput

High Throughput

Ontology Terms

growth abnormality (HP:0001507) [hct-116 cell (BTO:0001109)]

Additional Notes

shRNA
siRNA

Curated By

BioGRID

Interaction Summary

PTTG1

Gene Ontology Biological Process

Gene Ontology Molecular Function

cysteine-type endopeptidase inhibitor activity [NAS]protein binding [IPI]sequence-specific DNA binding transcription factor activity [TAS]

Gene Ontology Cellular Component

CASP3

Gene Ontology Biological Process

Gene Ontology Molecular Function

aspartic-type endopeptidase activity [EXP]cysteine-type endopeptidase activity [IDA, TAS]cysteine-type endopeptidase activity involved in apoptotic process [IMP]cysteine-type endopeptidase activity involved in execution phase of apoptosis [IMP]peptidase activity [IDA]protein binding [IPI]